Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Anderson Hoagland & Co.

Anderson Hoagland & Co. decreased its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 2.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 50,304 shares of the company’s stock after selling 1,380 shares during the period. Anderson Hoagland & Co.’s holdings in Ryan Specialty were worth $3,350,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in RYAN. Principal Financial Group Inc. boosted its position in shares of Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock worth $56,545,000 after buying an additional 509,548 shares during the period. Jennison Associates LLC grew its position in Ryan Specialty by 60.2% in the third quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock valued at $68,054,000 after acquiring an additional 385,366 shares in the last quarter. Eagle Asset Management Inc. raised its stake in shares of Ryan Specialty by 32.1% during the third quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock valued at $98,555,000 after purchasing an additional 335,180 shares during the period. Charles Schwab Investment Management Inc. raised its stake in shares of Ryan Specialty by 43.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock valued at $62,286,000 after purchasing an additional 286,380 shares during the period. Finally, Driehaus Capital Management LLC acquired a new position in shares of Ryan Specialty during the second quarter worth $16,313,000. 84.82% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, EVP Mark Stephen Katz sold 14,790 shares of the firm’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares of the company’s stock, valued at approximately $884,236.54. This trade represents a 54.42 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director David P. Bolger sold 7,055 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total transaction of $500,058.40. Following the completion of the sale, the director now directly owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. This represents a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 271,887 shares of company stock worth $18,118,273. Company insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently commented on RYAN. Morgan Stanley started coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target for the company. Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $79.00 to $77.00 and set an “outperform” rating on the stock in a research note on Friday, January 10th. Barclays lifted their price target on Ryan Specialty from $76.00 to $88.00 and gave the stock an “overweight” rating in a research note on Thursday, November 21st. Bank of America upped their price objective on Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a research note on Thursday, October 10th. Finally, The Goldman Sachs Group increased their target price on Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a report on Wednesday, October 9th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $74.40.

Ryan Specialty Price Performance

Shares of RYAN opened at $63.27 on Friday. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01. The company has a market cap of $16.57 billion, a P/E ratio of 82.16, a PEG ratio of 1.14 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a 12 month low of $42.21 and a 12 month high of $75.97. The stock has a fifty day moving average price of $67.34 and a 200 day moving average price of $66.21.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.41. The business had revenue of $604.69 million for the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The company’s revenue for the quarter was up 20.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.32 EPS. On average, research analysts forecast that Ryan Specialty Holdings, Inc. will post 1.82 earnings per share for the current year.

Ryan Specialty Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were issued a dividend of $0.11 per share. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 0.70%. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.